OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP. Share Price

Certificat

DE000GG0P633

Market Closed - BOERSE MUENCHEN 19:26:25 14/06/2024 BST
4.05 EUR 0.00% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP.
Current month+7.71%
1 month+65.31%
Date Price Change
14/06/24 4.05 0.00%
13/06/24 4.05 -9.40%
12/06/24 4.47 +3.95%
11/06/24 4.3 -2.93%
10/06/24 4.43 -6.34%

Real-time BOERSE MUENCHEN

Last update June 14, 2024 at 07:26 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GG0P63
ISINDE000GG0P633
Date issued 05/12/2023
Strike 299.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.54
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.21
Lowest since issue 0.252
Spread 0.07
Spread %1.63%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW